Statement of Ownership (sc 13g)
April 24 2020 - 6:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
(Amendment No. )*
|
Aikido Pharma Inc.
|
(Name of Issuer)
|
|
Common Stock, $0.0001 par value
|
(Title of Class of Securities)
|
|
008875106
|
(CUSIP Number)
|
|
April 14, 2020
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
|
☐
|
Rule 13d-1(b)
|
|
☒
|
Rule 13d-1(c)
|
|
☐
|
Rule 13d-1(d)
|
* The remainder of
this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
1
|
NAME OF REPORTING PERSONS
Altium Capital Management, LP
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2066653
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
(b) ☒
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States of America
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE VOTING
0
|
|
6
|
SHARED VOTING POWER
2,000,000 Shares of Common Stock
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
2,000,000 Shares of Common Stock
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,000 Shares of Common Stock
|
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.7%(1)
|
|
12
|
TYPE OF REPORTING PERSON
IA, PN
|
|
|
|
|
|
|
(1) Based
on 34,888,219 shares of Common Stock outstanding as of April 14, 2020 as set forth in the Issuer’s Prospectus Supplement
Form 424B5 filed with the Securities and Exchange Commission on April 15, 2020.
|
|
1
|
NAME OF REPORTING PERSONS
Altium Growth Fund, LP
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2105101
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
(b) ☒
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States of America
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE VOTING
0
|
|
6
|
SHARED VOTING POWER
2,000,000 Shares of Common Stock
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
2,000,000 Shares of Common Stock
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,000 Shares of Common Stock
|
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.7%(1)
|
|
12
|
TYPE OF REPORTING PERSON
PN
|
|
|
|
|
|
|
|
(1)
|
Based on 34,888,219 shares of Common Stock outstanding as of April 14, 2020 as set forth in the
Issuer’s Prospectus Supplement Form 424B5 filed with the Securities and Exchange Commission on April 15, 2020.
|
1
|
NAME OF REPORTING PERSONS
Altium Growth GP, LLC
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 82-2086430
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
(b) ☒
|
3
|
SEC USE ONLY
|
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States of America
|
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE VOTING
0
|
|
6
|
SHARED VOTING POWER
2,000,000 Shares of Common Stock
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
2,000,000 Shares of Common Stock
|
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,000,000 Shares of Common Stock
|
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.7%(1)
|
|
12
|
TYPE OF REPORTING PERSON
OO
|
|
|
(1)
|
Based on 34,888,219 shares of Common Stock outstanding as of April 14, 2020 as set forth in the
Issuer’s Prospectus Supplement Form 424B5 filed with the Securities and Exchange Commission on April 15, 2020.
|
Item 1(a).
|
|
Name of Issuer:
Aikido Pharma Inc. (the “Issuer”)
|
|
|
|
|
|
|
|
|
|
Item 1(b).
|
|
Address of Issuer’s Principal Executive Offices:
One
Rockefeller Plaza 11th Floor
New York, NY 10020
|
|
|
|
|
|
|
Item 2(a).
|
|
Name of Person Filing:
This statement is jointly filed by and on behalf
of each of Altium Growth Fund, LP, Altium Capital Management, LLC, and Altium Growth GP, LLC. Altium Growth Fund, LP is the record
and direct beneficial owner of the securities covered by this statement. Altium Capital Management, LP is the investment adviser
of, and may be deemed to beneficially own securities, owned by, Altium Growth Fund, LP. Altium Growth GP, LLC is the general partner
of, and may be deemed to beneficially own securities owned by, Altium Growth Fund, LP.
Each reporting person declares that neither the filing of this statement
nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act
or any other purpose, the beneficial owner of any securities covered by this statement.
Each of the reporting persons may be deemed
to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of
the Act. Each of the reporting persons declares that neither the filing of this statement nor anything herein shall be construed
as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or
has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group
for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any
securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.
|
|
|
|
|
|
|
|
|
|
Item 2(b).
|
|
Address of Principal Business Office or, if None, Residence:
|
|
|
The address of the principal business office of each of the reporting persons is
152 West 57 Street, FL 20, New York, NY 10019
|
|
|
|
|
|
|
|
|
|
Item 2(c).
|
|
Citizenship:
|
|
|
See Item 4 on the cover page(s) hereto.
|
|
|
|
|
|
|
Item 2(d).
|
|
Title of Class of Securities:
|
|
|
Common Stock, $0.0001 par value
|
|
|
|
|
|
|
Item 2(e).
|
|
CUSIP Number: 008875106
|
|
|
|
|
|
|
|
|
|
Item 3.
|
If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
|
|
|
(a)
|
☐
|
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
(b)
|
☐
|
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(c)
|
☐
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(d)
|
☐
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
(e)
|
☐
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
☐
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
☐
|
A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
|
|
|
|
|
|
(h)
|
☐
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
☐
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
☐
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
Item 4.
|
Ownership.
|
|
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified in Item 1.
The information as of the date of the event
which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page
for each Reporting Person listed above and is incorporated by reference for each such Reporting Person. The percentage set forth
in Row 11 of the cover page for each Reporting Person is based on 34,888,219 shares of Common Stock outstanding as of April 14,
2020 as set forth in the Issuer’s Prospectus Supplement Form 424B5 filed with the Securities and Exchange Commission on April
15, 2020.
|
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
|
|
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐
|
|
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
|
Not applicable
|
|
|
|
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
|
Not applicable
|
|
|
|
|
Item 8.
|
Identification and Classification of Members of the Group.
|
|
Not applicable
|
|
|
|
|
Item 9.
|
Notice of Dissolution of Group.
|
|
Not applicable
|
|
|
Item 10.
|
Certification.
|
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true, complete and correct.
|
Dated:
|
April
23, 2020
|
|
|
|
Altium
Capital Management, LP
|
|
|
|
By:
|
/s/
Jacob Gottlieb
|
|
Name:
|
Jacob
Gottlieb
|
|
Title:
|
CEO
|
|
|
|
|
Altium
Growth Fund, LP
|
|
|
|
|
By:
|
Altium
Growth GP, LLC
|
|
Its:
|
General
Partner
|
|
|
|
|
Signature:
|
/s/
Jacob Gottlieb
|
|
Name:
|
Jacob
Gottlieb
|
|
Title:
|
Managing
Member of Altium Growth GP, LLC
|
|
|
|
|
Altium
Growth GP, LLC
|
|
|
|
By:
|
/s/
Jacob Gottlieb
|
|
Name:
|
Jacob
Gottlieb
|
|
Title:
|
Managing
Member
|
EXHIBIT INDEX
EXHIBIT 1: Joint Acquisition Statement Pursuant to Section 240.13d-1(k)
Members of Group
EXHIBIT 1
JOINT ACQUISITION STATEMENT
PURSUANT TO SECTION 240.13d-1(k)
The undersigned acknowledge and agree that
the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this
statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint
acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments,
and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible
for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she
or it knows or has reason to believe that such information is inaccurate.
|
Dated:
|
April
23, 2020
|
|
|
|
Altium
Capital Management, LP
|
|
|
|
By:
|
/s/
Jacob Gottlieb
|
|
Name:
|
Jacob
Gottlieb
|
|
Title:
|
CEO
|
|
|
|
|
Altium
Growth Fund, LP
|
|
|
|
|
By:
|
Altium
Growth GP, LLC
|
|
Its:
|
General
Partner
|
|
|
|
|
Signature:
|
/s/
Jacob Gottlieb
|
|
Name:
|
Jacob
Gottlieb
|
|
Title:
|
Managing
Member of Altium Growth GP, LLC
|
|
|
|
|
Altium
Growth GP, LLC
|
|
|
|
By:
|
/s/
Jacob Gottlieb
|
|
Name:
|
Jacob
Gottlieb
|
|
Title:
|
Managing
Member
|
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Apr 2023 to Apr 2024